HeartSciences Inc. filed a Form 8-K on November 19, 2026, disclosing the voting results from a special meeting of shareholders held the same day, at which shareholders approved a merger agreement and a series of related proposals including a corporate name change to "Fortitude Mining Group, Inc."
Key Highlights
- Quorum achieved: 4,041,647 shares, or 76.36% of shares entitled to vote, were present virtually or by proxy at the Special Meeting.
- Merger approved: The Combination Proposal passed with 3,480,989 votes for, 20,933 against, and 3,150 abstentions.
- Name change approved: Shareholders voted 3,987,307 for and 39,842 against renaming the company to "Fortitude Mining Group, Inc."
- Stock issuance approved: The Nasdaq Proposal, permitting issuance of up to 35,000,000 additional shares of Class A Common Stock with aggregate consideration not to exceed $100,000,000, passed with 3,459,400 votes for.
- Reverse stock split authorized: Shareholders approved a potential one-for-two through one-for-five reverse split, at the board's discretion, with 3,981,498 votes for.
- Equity plan amended: The Plan Amendment Proposal passed with 3,207,036 votes for and 281,504 against.
- Record date and share counts: As of October 8, 2026, there were 4,949,283 shares of common stock and 343,516 shares issuable upon conversion of 380,440 shares of Series C Convertible Preferred Stock outstanding and entitled to vote.
HeartSciences Shareholders Vote on Merger, Capital Structure, and Rebranding
According to the filing, HeartSciences Inc. (NASDAQ:HSCS) held a special meeting of shareholders on November 19, 2026, at which six primary proposals and seven sub-proposals were submitted for a vote. The proposals were described in detail in the company's definitive proxy statement filed with the SEC on October 19, 2026, as supplemented by a Current Report on Form 8-K filed November 6, 2026, and definitive additional materials on Schedule 14A filed November 10, 2026.
The central Combination Proposal sought approval of the Agreement and Plan of Merger, as amended on July 27, 2026, and the transactions contemplated therein under the Texas Business Organizations Code. The filing reports that 3,480,989 shares were cast in favor, 20,933 against, and 3,150 abstained, with 536,575 broker non-votes. The accompanying Nasdaq Proposal, which included approval of share issuances and the change of control resulting from the transactions pursuant to Nasdaq Listing Rules 5635(a), 5635(b), and 5635(d), also passed, with 3,459,400 votes for and 43,445 against.
Among the Charter Adoption Proposals (3A through 3G), shareholders approved changing the company's name, adjusting par value from $0.001 to $0.0001 per share, designating 350,000,000 authorized shares as Class A Common Stock, designating 150,000,000 shares as Class V Common Stock, and establishing related governance provisions. The Adjournment Proposal also passed with 3,930,880 votes for, though the filing does not indicate the meeting was actually adjourned. The filing was signed by Andrew Simpson, President, Chief Executive Officer, and Chairman of the Board.
What Was Disclosed
HeartSciences Inc. reported the full voting results from its November 19, 2026 special shareholder meeting, covering approval of a merger agreement, corporate name change, share issuances, reverse stock split authorization, equity plan amendment, and related charter changes.




Please wait processing your request...